Logo Image
News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable DiscussionsShortsShows & Podcasts
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesParkinsonism Practical GuideSponsoredThe G.L.O.B.Virtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
  • Movement Disorders
    • Parkinson Disease
    • Dyskinesia
    • Huntington Disease
  • Neuro-Oncology
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Excessive Daytime Sleepiness
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
Upcoming Live Events|
CMSC 2026|
ATMRD 2026|
AAIC 2026|
Parkinsonism Practical Guide
Advertisement

Physicians' Education Resource (PER)

Advertisement

Physicians' Education Resource (PER) is the premier destination for healthcare continuing education, celebrating over 30 years of advancing physician education.


Learn more at gotoper.com

Articles by Physicians' Education Resource (PER)

3 Things You Should Know About Treating gMG With Novel Targeted Therapies

ByPhysicians' Education Resource (PER)
March 13th 2026

3 Things You Should Know About Spinal Muscular Atrophy

ByPhysicians' Education Resource (PER)
March 13th 2026

3 Things You Should Know About Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy

ByPhysicians' Education Resource (PER)
March 13th 2026

3 Things You Should Know About Chronic Inflammatory Demyelinating Polyneuropathy

ByPhysicians' Education Resource (PER)
March 13th 2026
Advertisement

Latest Updated Articles

  • 3 Things You Should Know About Treating gMG With Novel Targeted Therapies
    3 Things You Should Know About Treating gMG With Novel Targeted Therapies

    March 13th 2026

  • 3 Things You Should Know About Spinal Muscular Atrophy
    3 Things You Should Know About Spinal Muscular Atrophy

    March 13th 2026

  • 3 Things You Should Know About Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy
    3 Things You Should Know About Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy

    March 13th 2026

  • 3 Things You Should Know About Chronic Inflammatory Demyelinating Polyneuropathy
    3 Things You Should Know About Chronic Inflammatory Demyelinating Polyneuropathy

    March 13th 2026



Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1

2

FDA Grants RMAT Designation to Sasineprocel for Parkinson Disease

3

FDA Accepts SL1009 Resubmission for PDCD, Sets December PDUFA Date

4

High-Dose N-Acetyl Cysteine Associated With Reduced GFAP Levels in Phase 2 Progressive MS Study

5

B-Cell Depletion Persists Into Third Trimester After Ofatumumab Cessation, Real-World MS Cohort Finds

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us